Revenue Target from 4.7B to 100B KRW, 150~175B Non-Cash Funding Plan Announced

Long-term target: FY2030 consolidated revenue 100B KRW, ROE 7%+, PBR 3.5~4.5x
Short-term target: FY2026 break-even; cumulative operating loss of 17.45B KRW as of FY2025 remains a structural challenge
Non-cash funding of 150~175B KRW (capital debt + third-party allocation new shares) planned to enter four new business areas
Transitioning from a single bio-heavy oil business to an integrated platform of six business groups
Revenue improved from 4.7B to 20.85B KRW (CAGR +64%) and cost of sales ratio from 105% to 95% between FY2022 and FY2025
Not a high-dividend company; no dividend information provided

ADVERTISEMENT (250px+)